RTS activates p53-mediated cell cycle arrest and apoptotic pathways by inhibiting the cellular antioxidant defense system and massive accumulation of ROS in tumor cells and by inducing apoptosis and interrupting G2/M progression in HepG2 cells to inhibit the growth of tumor cells and promote apoptosis [17]. Here, TP53 is linked to neoplasm.